Literature DB >> 19249491

The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection.

H Xu1, X He, J Sun, D Shi, Y Zhu, X Zhang.   

Abstract

INTRODUCTION: B-cell activating factor, belonging to the tumor necrosis factor (TNF) superfamily (BAFF), plays an important role in the development and survival of B lymphocytes. The present study was to investigate the correlation of BAFF and complement residue C4d in kidney allograft biopsies.
METHODS: Transplant kidney biopsies as allograft were studied. 10 acute rejection (AR) cases, 3 interstitial fibrosis/tubular atrophy (IF/TA) cases, and 9 unknown etiology cases from January 1, 2001 to July 20, 2007 were analyzed. Transplanted kidneys were excised because of graft loss, and their pathological sections were studied. Ten other protocol biopsy specimens were studied. These recipients who received protocol biopsies had serum creatinine levels that were within normal range (normal value: < 144 micromol/L) from 2007. [corrected] BAFF, C4d, and immunoglobulin G (IgG) were detected by immunohistochemical stain methods. All were primary renal transplant recipients.
RESULTS: In AR and IF/TA cases, BAFF was strongly stained, similar to C4d. And BAFF and C4d were distributed in the perinephric tubular epithelial cell cytoplasm and cytomembrane. In the unknown etiology sections and protocol biopsy sections, BAFF was weakly or not expressed, similar to C4d. In BAFF and C4d high expression sections, weak or moderate IgG deposition was also found.
CONCLUSION: BAFF may be associated with the development of antibody-mediated allograft rejection in kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249491     DOI: 10.1016/j.transproceed.2008.10.037

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  16 in total

Review 1.  Biologic agents in islet transplantation.

Authors:  Boris Gala-Lopez; Andrew R Pepper; A M James Shapiro
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

2.  B cell modulation in transplantation.

Authors:  M R Clatworthy
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

3.  Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies.

Authors:  Eileen W Tsai; William D Wallace; David W Gjertson; Elaine F Reed; Robert B Ettenger
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

Review 4.  The generation and maintenance of serum alloantibody.

Authors:  M R Clatworthy; M Espeli; N Torpey; K G C Smith
Journal:  Curr Opin Immunol       Date:  2010-10       Impact factor: 7.486

5.  A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.

Authors:  Mariam Hammadi; Jacques-Olivier Pers; Christian Berthou; Pierre Youinou; Anne Bordron
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

6.  Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.

Authors:  Gemma Banham; Davide Prezzi; Sarah Harford; Craig J Taylor; Rizwan Hamer; Rob Higgins; J Andrew Bradley; Menna R Clatworthy
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

7.  Tolerogenic therapies in transplantation.

Authors:  Eugenia K Page; Wasim A Dar; Stuart J Knechtle
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

8.  Anti-BAFF Therapy: A New Tool to Target B Cells in Antibody-mediated Rejection?

Authors:  Sarah E Panzer
Journal:  Transplantation       Date:  2020-01       Impact factor: 5.385

9.  Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation.

Authors:  Jennifer R Zitzner; Anat R Tambur
Journal:  Cells       Date:  2012-05-10       Impact factor: 6.600

Review 10.  Spoiling for a Fight: B Lymphocytes As Initiator and Effector Populations within Tertiary Lymphoid Organs in Autoimmunity and Transplantation.

Authors:  Jawaher Alsughayyir; Gavin J Pettigrew; Reza Motallebzadeh
Journal:  Front Immunol       Date:  2017-11-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.